Citius Pharmaceuticals (CTXR) Price to Book (2014 - 2026)

Citius Pharmaceuticals (CTXR) has reported Price to Book for 13 consecutive years, with 0.22 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book fell 16.23% year-over-year to 0.22; the trailing twelve-month figure through Jun 2026 stood at 0.22 (down 16.23% YoY), and the FY2025 full-year result was 0.18, down 85.55% from the prior year.
• Price to Book retreated to 0.22 in Q2 2026 per CTXR's latest filing, from 0.29 in the prior quarter.
• Across five years, Price to Book topped out at 48481.44 in Q2 2023 and bottomed at 0.18 in Q3 2025.
• Historically, Price to Book has averaged 2712.69 across 5 years, with a median of 29.15 in 2023.
• The sharpest annual moves came in 2023 and 2024: Price to Book jumped 159057.32% in 2023, then slumped 99.94% in 2024.
• Over 5 years, Price to Book stood at 28.58 in 2022, then climbed by 23.32% to 35.25 in 2023, then tumbled by 98.73% to 0.45 in 2024, then tumbled by 58.36% to 0.19 in 2025, then increased by 16.2% to 0.22 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 0.22, 0.29, and 0.19 for Q2 2026, Q1 2026, and Q4 2025 respectively.